Real world initiation of newly funded empagliflozin and dulaglutide under special authority for patients with type 2 diabetes in New Zealand

被引：0
|
作者：
Lynne Chepulis [1 ]
Mark Rodrigues [1 ]
Han Gan [2 ]
Rawiri Keenan [1 ]
Tim Kenealy [3 ]
Rinki Murphy [3 ]
Leanne Te Karu [4 ]
Jo Scott-Jones [3 ]
Penny Clark [5 ]
Allan Moffitt [6 ]
Sara Mustafa [7 ]
Ross Lawrenson [1 ]
Ryan Paul [1 ]
机构：
[1] University of Waikato,Waikato Medical Research Centre
[2] University of Waikato,School of Computing and Mathematical Scienes
[3] University of Auckland,Faculty of Medical and Health Sciences
[4] Health New Zealand / Te Whatu Ora Te Toka Tumai,undefined
[5] Midlands Health Network,undefined
[6] Northcare Medical Centre,undefined
[7] Procare Health Limited,undefined
[8] Health New Zealand / Te Whatu Ora Waikato,undefined
来源：
BMC Health Services Research | / 25卷 / 1期
关键词：
SGLT2i; GLP1RA; Type 2 diabetes; Health system access;
D O I：
10.1186/s12913-025-12601-3
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Empagliflozin and dulaglutide: community awareness project promotes improved access to newly funded medications for Pacific patients with type 2 diabetes
    Sundborn, Gerhard
    Lesa, Fale
    King, Graham
    Vennell, Kate
    Kozak, Henry
    Pickering, Karen
    Baker, John
    NEW ZEALAND MEDICAL JOURNAL, 2023, 136 (1572) : 66 - 74
  • [2] REAL WORLD EFFECTIVENESS OF DULAGLUTIDE AMONG PATIENTS WITH TYPE 2 DIABETES
    Mody, R.
    Yu, M.
    Fernandez, L.
    Shui, A.
    Kallenbach, L.
    Slipski, L.
    de Oliveira, Piras C.
    VALUE IN HEALTH, 2017, 20 (05) : A164 - A164
  • [3] Effectiveness of Dulaglutide in the Real World and in Special Populations of Type 2 Diabetic Patients
    Morieri, Mario Luca
    Frison, Vera
    Rigato, Mauro
    D'Ambrosio, Michele
    Tadiotto, Federica
    Paccagnella, Agostino
    Simioni, Natalino
    Lapolla, Annunziata
    Avogaro, Angelo
    Fadini, Gian Paolo
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (07): : E2617 - E2625
  • [4] Impact of Early Initiation of Dulaglutide on MC in Patients with Type 2 Diabetes
    Hoog, Meredith
    Smith, Joseph L.
    Yu, Maria
    Peleshok, Jennifer
    Mody, Reema
    Grabner, Michael
    DIABETES, 2021, 70
  • [5] Real-World Effectiveness of Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Literature Review
    Susan Robinson
    Kristina S. Boye
    Reema Mody
    Alena Antonie Strizek
    Manige Konig
    Raleigh E. Malik
    Tessa Kennedy-Martin
    Diabetes Therapy, 2020, 11 : 1437 - 1466
  • [6] Real-World Effectiveness of Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Literature Review
    Robinson, Susan
    Boye, Kristina S.
    Mody, Reema
    Strizek, Alena Antonie
    Konig, Manige
    Malik, Raleigh E.
    Kennedy-Martin, Tessa
    DIABETES THERAPY, 2020, 11 (07) : 1437 - 1466
  • [7] Dulaglutide in type 2 diabetic elderly patients: a real world study
    Occhipinti, M.
    Turco, A.
    Baccetti, F.
    Cosimi, S.
    Cuccuru, I.
    Lacaria, E.
    Lencioni, C.
    Orsini, P.
    Bertoli, S.
    Di Carlo, A.
    Gregori, G.
    Di Cianni, G.
    DIABETOLOGIA, 2019, 62 : S288 - S288
  • [8] Real-world effectiveness of liraglutide versus dulaglutide in Japanese patients with type 2 diabetes: a retrospective study
    Kenichi Tanaka
    Yosuke Okada
    Akemi Tokutsu
    Yoshiya Tanaka
    Scientific Reports, 12
  • [9] Real-world effectiveness of liraglutide versus dulaglutide in Japanese patients with type 2 diabetes: a retrospective study
    Tanaka, Kenichi
    Okada, Yosuke
    Tokutsu, Akemi
    Tanaka, Yoshiya
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [10] Switching from insulin to dulaglutide therapy in patients with type 2 diabetes: A real-world data study
    Lee, Jiwoo
    Kim, Hwi Seung
    Jung, Chang Hee
    Park, Joong-Yeol
    Lee, Woo Je
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2021, 37 (08)
12345